WhaleCreep

Which hedge funds own 2655787D? BLUEPRINT MEDICINES CORP, Q2 2026 13F holders

0 tracked hedge funds disclosed a position in 2655787D (BLUEPRINT MEDICINES CORP) in their Q2 2026 13F filings, worth $0 in total.

0
Holders
0
New this quarter
0
Exited this quarter
$0
Combined value
–
Share of managers holding

Holders, Q2 2026

0 rows

Ownership over time

By quarter
QuarterHoldersManagers filingShare holdingCombined value
Q3 20250730.0%$0
Q2 20257739.6%$763m
Q1 20256738.2%$165m
Q4 202487410.8%$187m
Q3 20247739.6%$186m
Q2 202487311.0%$436m
Q1 202487311.0%$324m
Q4 20236738.2%$225m
Q3 20236738.2%$164m
Q2 20235736.8%$145m
Q1 20235736.8%$52.2m
Q4 20225736.8%$102m
Q3 20225746.8%$209m
Q2 20226748.1%$189m
Q1 20227749.5%$284m
Q4 20217749.5%$507m
Q3 202187111.3%$552m
Q2 202197112.7%$445m
Q1 202197012.9%$689m
Q4 20207719.9%$690m
Q3 20206688.8%$420m
Q2 20206688.8%$351m
Q1 20204685.9%$256m
Q4 20194676.0%$224m
Q3 20193605.0%$142m
Q2 20193605.0%$152m
Q1 20193605.0%$131m
Q4 20183605.0%$111m
Q3 20182593.4%$67.2m
Q2 20183595.1%$71.5m
Q1 20183595.1%$67.8m
Q4 20175598.5%$52.9m
Q3 20173565.4%$43.1m
Q2 20174567.1%$35.0m
Q1 20174567.1%$19.2m
Q4 20163565.4%$8.3m
Q3 20163525.8%$9.1m
Q2 20161521.9%$6.9m
Q1 20162523.8%$6.8m
Q4 20152523.8%$34.0m
Q3 20151521.9%$18.7m
Q2 20151521.9%$23.3m

Who discovered 2655787D first?

Earliest meaningful positions among the 15 tracked managers seen opening 2655787D since Q2 2015.

3 rows
RA Capital Management, L.P.Q2 20152.5%2.7%4Exited by Q2 2016−32%
Lone Pine Capital LLCQ4 20201.1%1.1%2Exited by Q2 2021−13%
Avidity Partners Management LPQ4 20200.9%2.3%14Exited by Q2 2025−21%

Stock since is the split-adjusted change in the quarter-end price, excluding dividends, from the first reported quarter: the price the 13F filings themselves imply (value ÷ shares), blank across any gap that cannot be accounted for. It describes the stock, not the return any manager earned.

1 already held it when coverage began

Casdin Capital, LLC (Q4 2015)